Trial intelligence / Profile preview

NS2359 for Cocaine Dependence

NCT02798627Phase 2Completed

Sponsor
University of Pennsylvania
Start
May 2016
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of NS2359 in cocaine use disorder (CUD), sponsored by University of Pennsylvania. Started May 2016; status: completed.

02

Drugs

NS2359
03

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on NCT02798627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02798627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call